{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:16:48Z","timestamp":1788311808249,"version":"build-2803163510"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-026-01609-9","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:57:18Z","timestamp":1782107838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers"],"prefix":"10.1186","volume":"16","author":[{"given":"Emanuela","family":"Mari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Aventaggiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Paldino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Mantuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Dugheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-3162","authenticated-orcid":false,"given":"Stefano","family":"Martellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"4","key":"1609_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1152\/physrev.00006.2009","volume":"89","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev. 2009;89(4):1109\u201352.","journal-title":"Physiol Rev"},{"key":"1609_CR2","first-page":"172","volume":"308","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M. The prion-like properties of amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Neuroscience. 2015;308:172\u201381.","journal-title":"Neuroscience"},{"issue":"23","key":"1609_CR3","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB, Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5794","key":"1609_CR4","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser SA, Schaefer C, Aguzzi A, et al. Exogenous A\u03b2-seeding induces \u03b2-amyloidosis in \u03b2APP-transgenic mice. Science. 2006;313(5794):1781\u20134.","journal-title":"Science"},{"issue":"7465","key":"1609_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501(7465):45\u201351.","journal-title":"Nature"},{"issue":"2","key":"1609_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","volume":"51","author":"N Stahl","year":"1987","unstructured":"Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987;51(2):229\u201340. https:\/\/doi.org\/10.1016\/0092-8674(87)90150-4.","journal-title":"Cell"},{"issue":"1","key":"1609_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1073\/pnas.97.1.145","volume":"97","author":"R Zahn","year":"2000","unstructured":"Zahn R, Liu A, L\u00fchrs T, Riek R, von Schroetter C, L\u00f3pez Garc\u00eda F, et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A. 2000;97(1):145\u201350. https:\/\/doi.org\/10.1073\/pnas.97.1.145.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1609_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1152\/physrev.00007.2007","volume":"88","author":"R Linden","year":"2008","unstructured":"Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev. 2008;88(2):673\u2013728. https:\/\/doi.org\/10.1152\/physrev.00007.2007.","journal-title":"Physiol Rev"},{"issue":"11","key":"1609_CR9","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.3390\/ijms21114168","volume":"21","author":"S Martellucci","year":"2020","unstructured":"Martellucci S, Santacroce C, Santilli F, Manganelli V, Sorice M, Mattei V. Prion protein in stem cells: a lipid raft component involved in the cellular differentiation process. Int J Mol Sci. 2020;21(11):4168. https:\/\/doi.org\/10.3390\/ijms21114168.","journal-title":"Int J Mol Sci"},{"key":"1609_CR10","doi-asserted-by":"publisher","first-page":"e59282","DOI":"10.3791\/59282","volume":"145","author":"S Martellucci","year":"2019","unstructured":"Martellucci S, Santacroce C, Manganelli V, Santilli F, Piccoli L, Cassetta M, et al Isolation, propagation, and prion protein expression during neuronal differentiation of human dental pulp stem cells. J Vis Exp. 2019;145:e59282. . https:\/\/doi.org\/10.3791\/59282.","journal-title":"J Vis Exp"},{"key":"1609_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/35081095","volume":"411","author":"GP Saborio","year":"2001","unstructured":"Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810\u20133.","journal-title":"Nature"},{"key":"1609_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17:175\u20138.","journal-title":"Nat Med"},{"key":"1609_CR13","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1212\/WNL.0000000000005860","volume":"91","author":"P Hermann","year":"2018","unstructured":"Hermann P, Laux M, Glatzel M, Jan\u00dfen P, Zerr I, Grampp T, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91:e331\u20138.","journal-title":"Neurology"},{"key":"1609_CR14","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s12035-018-1251-1","volume":"56","author":"A Villar-Piqu\u00e9","year":"2019","unstructured":"Villar-Piqu\u00e9 A, Schmitz M, Hermann P, Goebel S, Bunck T, Varges D, et al. Cerebrospinal fluid total prion protein in the spectrum of prion diseases. Mol Neurobiol. 2019;56:2811\u201321.","journal-title":"Mol Neurobiol"},{"key":"1609_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/nan.12573","volume":"46","author":"F Llorens","year":"2020","unstructured":"Llorens F, Schmitz M, Cramm M, Requena JR, Schoenfeld R, Zafar S, et al. Plasma total prion protein as a potential biomarker for neurodegenerative dementia. Neuropathol Appl Neurobiol. 2020;46:240\u201354.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"1609_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4161\/cib.19145","volume":"5","author":"M Sorice","year":"2012","unstructured":"Sorice M, Mattei V, Matarrese P, Garofalo T, Tinari A, Gambardella L, Ciarlo L, Manganelli V, Tasciotti V, Misasi R, Malorni W. Dynamics of mitochondrial raft-like microdomains in cell life and death. Commun Integr Biol. 2012;5(2):217\u20139. https:\/\/doi.org\/10.4161\/cib.19145.","journal-title":"Commun Integr Biol"},{"issue":"4","key":"1609_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1051\/vetres:2007048","volume":"39","author":"V Zomosa-Signoret","year":"2008","unstructured":"Zomosa-Signoret V, Arnaud JD, Fontes P, Alvarez-Martinez MT, Liautard JP. Physiological role of the cellular prion protein. Vet Res. 2008;39(4):9. https:\/\/doi.org\/10.1051\/vetres:2007048.","journal-title":"Vet Res"},{"issue":"10","key":"1609_CR18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00109-022-02245-9","volume":"100","author":"I Grimaldi","year":"2022","unstructured":"Grimaldi I, Leser FS, Janeiro JM, Gama CS, Fernandes S, Nunes M, et al. The multiple functions of PrP in physiological, cancer, and neurodegenerative contexts. J Mol Med (Berl). 2022;100(10):1405\u201325. https:\/\/doi.org\/10.1007\/s00109-022-02245-9.","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"1609_CR19","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/ijms23031232","volume":"23","author":"V Kova\u010d","year":"2022","unstructured":"Kova\u010d V, \u0160erbec V. Prion protein: the molecule of many forms and face. Int J Mol Sci. 2022;23(3):1232. https:\/\/doi.org\/10.3390\/ijms23031232.","journal-title":"Int J Mol Sci"},{"key":"1609_CR20","doi-asserted-by":"publisher","unstructured":"Burato A, Di Clemente A, Lodetti C, Panico V, Pistorio G, Mizusaki BP, Pastore B, Zattoni M, Celauro L, Zanetti L, Sadiraj L, Piasini E, Giugliano M, Reinhard K, Legname G. Prion protein deficiency results in synaptic, neural network and behavioral alterations. bioRxiv https:\/\/doi.org\/10.64898\/2026.04.07.716931","DOI":"10.64898\/2026.04.07.716931"},{"issue":"1","key":"1609_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biologics6010001","volume":"6","author":"N Candelise","year":"2026","unstructured":"Candelise N, Orefice NS, Mantuano E, Martellucci S. Targeting the cellular prion protein as a biomarker for stem cells, cancer, and regeneration. Biologics. 2026;6(1):1. https:\/\/doi.org\/10.3390\/biologics6010001","journal-title":"Biologics"},{"issue":"1","key":"1609_CR22","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1038\/s41467-024-51931-4","volume":"15","author":"D Karner","year":"2024","unstructured":"Karner D, Kvestak D, Kucan Brlic P, Cokaric Brdovcak M, Lisnic B, Brizic I, et al. Prion protein alters viral control and enhances pathology after perinatal cytomegalovirus infection. Nat Commun. 2024;15(1):7754. https:\/\/doi.org\/10.1038\/s41467-024-51931-4.","journal-title":"Nat Commun"},{"issue":"3","key":"1609_CR23","first-page":"319","volume":"61","author":"DR Brown","year":"2003","unstructured":"Brown DR, Harris DA. Copper and prion protein function. Brain Res Bull. 2003;61(3):319\u201328.","journal-title":"Brain Res Bull"},{"key":"1609_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcell.2014.00044","volume":"2","author":"L Gasperini","year":"2014","unstructured":"Gasperini L, Legname G. Prion protein and aging. Front Cell Dev Biol. 2014;2:44. https:\/\/doi.org\/10.3389\/fcell.2014.00044.","journal-title":"Front Cell Dev Biol"},{"issue":"6487","key":"1609_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/370295a0","volume":"370","author":"J Collinge","year":"1994","unstructured":"Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, et al. Prion protein is necessary for normal synaptic function. Nature. 1994;370(6487):295\u20137. https:\/\/doi.org\/10.1038\/370295a0.","journal-title":"Nature"},{"issue":"1","key":"1609_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336896.2016.1245292","volume":"11","author":"J Kanaani","year":"2017","unstructured":"Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G. Neuronal and glial functions of the prion protein. Prion. 2017;11(1):1\u201322. https:\/\/doi.org\/10.1080\/19336896.2016.1245292.","journal-title":"Prion"},{"issue":"6741","key":"1609_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/22241","volume":"400","author":"C Kuwahara","year":"1999","unstructured":"Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, et al. Prions prevent neuronal cell-line death. Nature. 1999;400(6741):225\u20136. https:\/\/doi.org\/10.1038\/22241.","journal-title":"Nature"},{"key":"1609_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","volume":"15","author":"MA Wulf","year":"2017","unstructured":"Wulf MA, Senatore A, Aguzzi A. The biological function of the cellular prion protein: an update. BMC Biol. 2017;15:34. https:\/\/doi.org\/10.1186\/s12915-017-0375-5.","journal-title":"BMC Biol"},{"issue":"41","key":"1609_CR29","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1074\/jbc.RA120.013779","volume":"295","author":"E Mantuano","year":"2020","unstructured":"Mantuano E, Azmoon P, Banki MA, Lam MS, Sigurdson CJ, Gonias SL. A soluble derivative of PrPC activates cell signaling and regulates cell physiology through LRP1 and the NMDA receptor. J Biol Chem. 2020;295(41):14178\u201388. https:\/\/doi.org\/10.1074\/jbc.RA120.013779.","journal-title":"J Biol Chem"},{"issue":"4","key":"1609_CR30","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jnc.14891","volume":"152","author":"V Mattei","year":"2020","unstructured":"Mattei V, Manganelli V, Martellucci S, Capozzi A, Mantuano E, Longo A, et al. A multimolecular signaling complex including PrPC and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator. J Neurochem. 2020;152(4):468\u201381. https:\/\/doi.org\/10.1111\/jnc.14891.","journal-title":"J Neurochem"},{"issue":"7233","key":"1609_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-\u03b2 oligomers. Nature. 2009;457(7233):1128\u201332. https:\/\/doi.org\/10.1038\/nature07761.","journal-title":"Nature"},{"issue":"9","key":"1609_CR32","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, et al. Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci. 2012;15(9):1227\u201335. https:\/\/doi.org\/10.1038\/nn.3178.","journal-title":"Nat Neurosci"},{"issue":"11","key":"1609_CR33","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4634","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Vicente Miranda H, Batalha VL, Coelho JE, Szeg\u0151 \u00c9M, et al. \u03b1-Synuclein interacts with PrPC to induce cognitive impairment. Nat Neurosci. 2017;20(11):1569\u201379. https:\/\/doi.org\/10.1038\/nn.4634.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1609_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/19336896.2017.1423186","volume":"12","author":"E De Cecco","year":"2018","unstructured":"De Cecco E, Legname G. The role of the prion protein in the internalization of \u03b1-synuclein amyloids. Prion. 2018;12(1):23\u20137. https:\/\/doi.org\/10.1080\/19336896.2017.1423186.","journal-title":"Prion"},{"issue":"4","key":"1609_CR35","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/brain\/awy080","volume":"141","author":"T Ondrejcak","year":"2018","unstructured":"Ondrejcak T, Klyubin I, Corbett GT, Fraser G, Hong W, Mably AJ, et al. Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau. Brain. 2018;141(4):1328\u201338. https:\/\/doi.org\/10.1093\/brain\/awy080.","journal-title":"Brain"},{"issue":"11 Pt B","key":"1609_CR36","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.bbamcr.2017.06.022","volume":"1864","author":"L Linsenmeier","year":"2017","unstructured":"Linsenmeier L, Altmeppen HC, Wetzel S, Mohammadi B, Saftig P, Glatzel M. Diverse functions of the prion protein: does proteolytic processing hold the key? Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt B):2128\u201337. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.06.022.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"32","key":"1609_CR37","doi-asserted-by":"publisher","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","volume":"270","author":"SG Chen","year":"1995","unstructured":"Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem. 1995;270(32):19173\u201380. https:\/\/doi.org\/10.1074\/jbc.270.32.19173.","journal-title":"J Biol Chem"},{"issue":"2","key":"1609_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biolcel.2003.11.007","volume":"96","author":"A Mang\u00e9","year":"2004","unstructured":"Mang\u00e9 A, B\u00e9ranger F, Peoc\u2019h K, Onodera T, Frobert Y, Lehmann S. Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein. Biol Cell. 2004;96(2):125\u201332. https:\/\/doi.org\/10.1016\/j.biolcel.2003.11.007.","journal-title":"Biol Cell"},{"issue":"25","key":"1609_CR39","doi-asserted-by":"publisher","first-page":"13452","DOI":"10.1073\/pnas.94.25.13452","volume":"94","author":"DG Donne","year":"1997","unstructured":"Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE, et al. Structure of the recombinant full-length hamster prion protein PrP(29\u2013231): the N terminus is highly flexible. Proc Natl Acad Sci U S A. 1997;94(25):13452\u20137. https:\/\/doi.org\/10.1073\/pnas.94.25.13452.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"1609_CR40","doi-asserted-by":"publisher","first-page":"37743","DOI":"10.1074\/jbc.M105677200","volume":"276","author":"B Vincent","year":"2001","unstructured":"Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem. 2001;276(41):37743\u20136. https:\/\/doi.org\/10.1074\/jbc.M105677200.","journal-title":"J Biol Chem"},{"issue":"49","key":"1609_CR41","doi-asserted-by":"publisher","first-page":"40624","DOI":"10.1074\/jbc.M506069200","volume":"280","author":"MA Ciss\u00e9","year":"2005","unstructured":"Ciss\u00e9 MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B, Checler F. The disintegrin ADAM9 indirectly contributes to physiological processing of cellular prion protein by modulating ADAM10 activity. J Biol Chem. 2005;280(49):40624\u201331. https:\/\/doi.org\/10.1074\/jbc.M506069200.","journal-title":"J Biol Chem"},{"issue":"38","key":"1609_CR42","doi-asserted-by":"publisher","first-page":"13255","DOI":"10.1523\/JNEUROSCI.2236-12.2012","volume":"32","author":"M B\u00e9land","year":"2012","unstructured":"B\u00e9land M, Motard J, Barbarin A, Roucou X. PrPC homodimerization stimulates the production of PrPN1 and PrPC1 fragments. J Neurosci. 2012;32(38):13255\u201363. https:\/\/doi.org\/10.1523\/JNEUROSCI.2236-12.2012.","journal-title":"J Neurosci"},{"issue":"5","key":"1609_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4161\/pri.22588","volume":"6","author":"L Wik","year":"2012","unstructured":"Wik L, Klingeborn M, Willander H, Linne T. Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion. 2012;6(5):498\u2013509. https:\/\/doi.org\/10.4161\/pri.22588.","journal-title":"Prion"},{"issue":"21","key":"1609_CR44","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1016\/S0021-9258(18)82340-7","volume":"268","author":"SL Shyng","year":"1993","unstructured":"Shyng SL, Huber MT, Harris DA. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem. 1993;268(21):15922\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"1609_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1083\/jcb.129.1.121","volume":"129","author":"A Taraboulos","year":"1995","unstructured":"Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol. 1995;129(1):121\u201332. https:\/\/doi.org\/10.1083\/jcb.129.1.121.","journal-title":"J Cell Biol"},{"issue":"2","key":"1609_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.mcn.2008.10.012","volume":"40","author":"AR Walmsley","year":"2009","unstructured":"Walmsley AR, Watt NT, Taylor DR, Perera WS, Hooper NM. Alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci. 2009;40(2):242\u20138. https:\/\/doi.org\/10.1016\/j.mcn.2008.10.012.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"1609_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2005.09.031","volume":"337","author":"H Tveit","year":"2005","unstructured":"Tveit H, Lund C, Olsen CM, Ersdal C, Prydz K, Harbitz I, et al. Proteolytic processing of the ovine prion protein in cell cultures. Biochem Biophys Res Commun. 2005;337(1):232\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2005.09.031.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1609_CR48","first-page":"15","volume":"1","author":"HC Altmeppen","year":"2012","unstructured":"Altmeppen HC, Puig B, Dohler F, Thurm DK, Falker C, Krasemann S, et al. Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis. 2012;1(1):15\u201331.","journal-title":"Am J Neurodegener Dis"},{"issue":"21","key":"1609_CR49","doi-asserted-by":"publisher","first-page":"8020","DOI":"10.1074\/jbc.RA117.000990","volume":"293","author":"AD Engelke","year":"2018","unstructured":"Engelke AD, Gonsberg A, Thapa S, Jung S, Ulbrich S, Seidel RT, et al. Dimerization of the cellular prion protein inhibits propagation of scrapie prions. J Biol Chem. 2018;293(21):8020\u201331. https:\/\/doi.org\/10.1074\/jbc.RA117.000990.","journal-title":"J Biol Chem"},{"key":"1609_CR50","doi-asserted-by":"publisher","first-page":"e04260","DOI":"10.7554\/eLife.04260","volume":"4","author":"HC Altmeppen","year":"2015","unstructured":"Altmeppen HC, Prox J, Krasemann S, Puig B, Kluth MA, Bernreuther C, et al. The sheddase ADAM10 is a potent modulator of prion disease. Elife. 2015;4:e04260. https:\/\/doi.org\/10.7554\/eLife.04260.","journal-title":"Elife"},{"issue":"4","key":"1609_CR51","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/19336896.2015.1065371","volume":"9","author":"M Glatzel","year":"2015","unstructured":"Glatzel M, Linsenmeier L, Dohler F, Krasemann S, Puig B, Altmeppen HC. Shedding light on prion disease. Prion. 2015;9(4):244\u201356. https:\/\/doi.org\/10.1080\/19336896.2015.1065371.","journal-title":"Prion"},{"issue":"2","key":"1609_CR52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1074\/jbc.M113.502351","volume":"289","author":"AJ McDonald","year":"2014","unstructured":"McDonald AJ, Dibble JP, Evans EG, Millhauser GL. A new paradigm for enzymatic control of \u03b1-cleavage and \u03b2-cleavage of the prion protein. J Biol Chem. 2014;289(2):803\u201313. https:\/\/doi.org\/10.1074\/jbc.M113.502351.","journal-title":"J Biol Chem"},{"issue":"43","key":"1609_CR53","doi-asserted-by":"publisher","first-page":"35914","DOI":"10.1074\/jbc.M507327200","volume":"280","author":"NT Watt","year":"2005","unstructured":"Watt NT, Taylor DR, Gillott A, Thomas DA, Perera WS, Hooper NM. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem. 2005;280(43):35914\u201321. https:\/\/doi.org\/10.1074\/jbc.M507327200.","journal-title":"J Biol Chem"},{"issue":"3","key":"1609_CR54","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1074\/jbc.M007243200","volume":"276","author":"HE McMahon","year":"2001","unstructured":"McMahon HE, Mang\u00e9 A, Nishida N, Cr\u00e9minon C, Casanova D, Lehmann S. Cleavage of the amino-terminus of the prion protein by reactive oxygen species. J Biol Chem. 2001;276(3):2286\u201391. https:\/\/doi.org\/10.1074\/jbc.M007243200.","journal-title":"J Biol Chem"},{"issue":"25","key":"1609_CR55","doi-asserted-by":"publisher","first-page":"13937","DOI":"10.1073\/pnas.250289197","volume":"97","author":"O Milhavet","year":"2000","unstructured":"Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mang\u00e9 A, et al. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci U S A. 2000;97(25):13937\u201342. https:\/\/doi.org\/10.1073\/pnas.250289197.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1609_CR56","doi-asserted-by":"publisher","first-page":"13090","DOI":"10.1038\/s41598-019-49482-6","volume":"9","author":"A Ashok","year":"2019","unstructured":"Ashok A, Kang MH, Wise AS, Pattabiraman P, Johnson WM, Lonigro M, et al. Prion protein modulates endothelial-to-mesenchyme-like transition in trabecular meshwork cells: implications for primary open-angle glaucoma. Sci Rep. 2019;9(1):13090. https:\/\/doi.org\/10.1038\/s41598-019-49482-6.","journal-title":"Sci Rep"},{"issue":"1","key":"1609_CR57","doi-asserted-by":"publisher","first-page":"e2209815120","DOI":"10.1073\/pnas.2209815120","volume":"120","author":"AR Castle","year":"2023","unstructured":"Castle AR, Kang SG, Eskandari-Sedighi G, Wohlgemuth S, Nguyen MA, Drucker DJ, et al. Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proc Natl Acad Sci U S A. 2023;120(1):e2209815120. https:\/\/doi.org\/10.1073\/pnas.2209815120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1609_CR58","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00018-014-177726","volume":"72","author":"CL Haigh","year":"2015","unstructured":"Haigh CL, McGlade AR, Collins SJ. MEK1 transduces the prion protein N2 fragment antioxidant effects. Cell Mol Life Sci. 2015;72(8):1613\u201329. https:\/\/doi.org\/10.1007\/s00018-014-177726.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1609_CR59","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1038\/s41467-023-43961-1","volume":"14","author":"JM Ribes","year":"2023","unstructured":"Ribes JM, Patel MP, Halim HA, Berretta A, Tooze SA, Kl\u00f6hn PC. Prion protein conversion at two distinct cellular sites precedes fibrillisation. Nat Commun. 2023;14(1):8354. https:\/\/doi.org\/10.1038\/s41467-023-43961-1.","journal-title":"Nat Commun"},{"issue":"14","key":"1609_CR60","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1074\/jbc.M109.083857","volume":"285","author":"M Dron","year":"2010","unstructured":"Dron M, Moudjou M, Chapuis J, Salamat MKF, Bernard J, Cronier S, et al. Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J Biol Chem. 2010;285(14):10252\u201364. https:\/\/doi.org\/10.1074\/jbc.M109.083857.","journal-title":"J Biol Chem"},{"issue":"3","key":"1609_CR61","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00018-015-2022-z","volume":"73","author":"V Lewis","year":"2016","unstructured":"Lewis V, Johanssen VA, Crouch PJ, Klug GM, Hooper NM, Collins SJ. Prion protein gamma-cleavage: characterizing a novel endoproteolytic processing event. Cell Mol Life Sci. 2016;73(3):667\u201383. https:\/\/doi.org\/10.1007\/s00018-015-2022-z.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1609_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/1673-5374.177726","volume":"11","author":"CL Haigh","year":"2016","unstructured":"Haigh CL, Collins SJ. Endoproteolytic cleavage as a molecular switch regulating and diversifying prion protein function. Neural Regen Res. 2016;11(2):238\u20139. https:\/\/doi.org\/10.4103\/1673-5374.177726.","journal-title":"Neural Regen Res"},{"issue":"2","key":"1609_CR63","doi-asserted-by":"publisher","first-page":"102823","DOI":"10.1016\/j.jbc.2022.102823","volume":"299","author":"I Vanni","year":"2023","unstructured":"Vanni I, Iacobone F, D\u2019Agostino C, Giovannelli M, Pirisinu L, Altmeppen HC, et al. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein. J Biol Chem. 2023;299(2):102823. https:\/\/doi.org\/10.1016\/j.jbc.2022.102823.","journal-title":"J Biol Chem"},{"issue":"2","key":"1609_CR64","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/biom4020510","volume":"4","author":"A Kojima","year":"2014","unstructured":"Kojima A, Konishi M, Akizawa T. Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu\u00b2\u207a-binding. Biomolecules. 2014;4(2):510\u201326. https:\/\/doi.org\/10.3390\/biom4020510.","journal-title":"Biomolecules"},{"issue":"38","key":"1609_CR65","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.1021\/bi00490a001","volume":"29","author":"N Stahl","year":"1990","unstructured":"Stahl N, Baldwin MA, Burlingame AL, Prusiner SB. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry. 1990;29(38):8879\u201384. https:\/\/doi.org\/10.1021\/bi00490a001.","journal-title":"Biochemistry"},{"issue":"4","key":"1609_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/glycob\/3.4.319","volume":"3","author":"DR Borchelt","year":"1993","unstructured":"Borchelt DR, Rogers M, Stahl N, Telling G, Prusiner SB. Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology. 1993;3(4):319\u201329. https:\/\/doi.org\/10.1093\/glycob\/3.4.319.","journal-title":"Glycobiology"},{"issue":"4","key":"1609_CR67","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1021\/bi00055a003","volume":"32","author":"DA Harris","year":"1993","unstructured":"Harris DA, Huber MT, van Dijken P, Shyng SL, Chait BT, Wang R. Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry. 1993;32(4):1009\u201316. https:\/\/doi.org\/10.1021\/bi00055a003.","journal-title":"Biochemistry"},{"issue":"1","key":"1609_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00401-024-02763-5","volume":"148","author":"F Song","year":"2024","unstructured":"Song F, Kovac V, Mohammadi B, Littau JL, Scharfenberg F 3, Angles M. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases. Acta Neuropathol. 2024;148(1):2. https:\/\/doi.org\/10.1007\/s00401-024-02763-5.","journal-title":"Acta Neuropathol"},{"issue":"48","key":"1609_CR69","doi-asserted-by":"publisher","first-page":"44627","DOI":"10.1074\/jbc.M107458200","volume":"276","author":"P Parizek","year":"2001","unstructured":"Parizek P, Roeckl C, Weber J, Flechsig E, Aguzzi A, Raeber AJ. Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem. 2001;276(48):44627\u201332. https:\/\/doi.org\/10.1074\/jbc.M107458200.","journal-title":"J Biol Chem"},{"issue":"7465","key":"1609_CR70","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12402","volume":"501","author":"T Sonati","year":"2013","unstructured":"Sonati T, Reimann RR, Falsig J, Baral PK, O\u2019Connor T, Hornemann S, et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature. 2013;501(7465):102\u20136. https:\/\/doi.org\/10.1038\/nature12402.","journal-title":"Nature"},{"issue":"48","key":"1609_CR71","doi-asserted-by":"publisher","first-page":"eabj1826","DOI":"10.1126\/sciadv.abj1826","volume":"7","author":"L Linsenmeier","year":"2021","unstructured":"Linsenmeier L, Mohammadi B, Shafiq M, Frontzek K, B\u00e4r J, Shrivastava AN, et al. Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies. Sci Adv. 2021;7(48):eabj1826. https:\/\/doi.org\/10.1126\/sciadv.abj1826.","journal-title":"Sci Adv"},{"key":"1609_CR72","doi-asserted-by":"publisher","first-page":"117727191875664","DOI":"10.1177\/1177271918756648","volume":"13","author":"V Kova\u010d","year":"2018","unstructured":"Kova\u010d V. \u010curin \u0160erbec V. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases. Biomark Insights. 2018;13:1177271918756648. https:\/\/doi.org\/10.1177\/1177271918756648.","journal-title":"Biomark Insights"},{"issue":"34","key":"1609_CR73","doi-asserted-by":"publisher","first-page":"22590","DOI":"10.1074\/jbc.M109.032599","volume":"284","author":"DR Taylor","year":"2009","unstructured":"Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, et al. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem. 2009;284(34):22590\u2013225600. https:\/\/doi.org\/10.1074\/jbc.M109.032599.","journal-title":"J Biol Chem"},{"key":"1609_CR74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-1326-6-36","volume":"6","author":"HC Altmeppen","year":"2011","unstructured":"Altmeppen HC, Prox J, Puig B, Kluth MA, Bernreuther C, Thurm D, et al. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener. 2011;6:36. https:\/\/doi.org\/10.1186\/1750-1326-6-36.","journal-title":"Mol Neurodegener"},{"key":"1609_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.10.003","volume":"135","author":"P Saftig","year":"2015","unstructured":"Saftig P, Lichtenthaler SF. The alpha secretase ADAM10: a metalloprotease with multiple functions in the brain. Prog Neurobiol. 2015;135:1\u201320. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.10.003.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1609_CR76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12987-016-0038-x","volume":"13","author":"B Shackleton","year":"2016","unstructured":"Shackleton B, Crawford F, Bachmeier C. Inhibition of ADAM10 promotes the clearance of A\u03b2 across the BBB by reducing LRP1 ectodomain shedding. Fluids Barriers CNS. 2016;13(1):14. https:\/\/doi.org\/10.1186\/s12987-016-0038-x.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"1609_CR77","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1681\/ASN.2020081213","volume":"32","author":"M Sachs","year":"2021","unstructured":"Sachs M, Wetzel S, Reichelt J, Wiebke S, Schebsdat L, Zielinski S, et al. ADAM10-Mediated ectodomain shedding is an essential driver of podocyte damage. J Am Soc Nephrol. 2021;32(6):1389\u2013408. https:\/\/doi.org\/10.1681\/ASN.2020081213.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1609_CR78","doi-asserted-by":"publisher","first-page":"e1007520","DOI":"10.1371\/journal.ppat.1007520","volume":"15","author":"B Puig","year":"2019","unstructured":"Puig B, Altmeppen HC, Linsenmeier L, Chakrown K, Wegwitz F, Piontek Uk, et al. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLoS Pathog. 2019;15(1):e1007520. https:\/\/doi.org\/10.1371\/journal.ppat.1007520.","journal-title":"PLoS Pathog"},{"issue":"6420","key":"1609_CR79","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/362543a0","volume":"362","author":"G Forloni","year":"1993","unstructured":"Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, et al. Neurotoxicity of a prion protein fragment. Nature. 1993;362(6420):543\u20136. https:\/\/doi.org\/10.1038\/362543a0.","journal-title":"Nature"},{"issue":"9","key":"1609_CR80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14737175.2021.1965881","volume":"21","author":"E Dexter","year":"2021","unstructured":"Dexter E, Kong Q. Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review. Expert Rev Neurother. 2021;21(9):969\u201382. https:\/\/doi.org\/10.1080\/14737175.2021.1965881.","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"1609_CR81","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/14737175.2021.1965882","volume":"21","author":"E Dexter","year":"2021","unstructured":"Dexter E, Kong Q. Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development. Expert Rev Neurother. 2021;21(9):983\u201391. https:\/\/doi.org\/10.1080\/14737175.2021.1965882.","journal-title":"Expert Rev Neurother"},{"issue":"6572","key":"1609_CR82","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/380345a0","volume":"380","author":"DR Brown","year":"1996","unstructured":"Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 1996;380(6572):345\u20137. https:\/\/doi.org\/10.1038\/380345a0.","journal-title":"Nature"},{"issue":"11","key":"1609_CR83","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/cells14110851","volume":"14","author":"M Zayed","year":"2025","unstructured":"Zayed M, Jeong BH. Mesenchymal stem cell secretome attenuates PrP106-126-induced neurotoxicity by suppressing neuroinflammation and apoptosis and enhances cell migration. Cells. 2025;14(11):851. https:\/\/doi.org\/10.3390\/cells14110851.","journal-title":"Cells"},{"issue":"6","key":"1609_CR84","doi-asserted-by":"publisher","first-page":"119240","DOI":"10.1016\/j.bbamcr.2022.119240","volume":"1869","author":"M Shafiq","year":"2022","unstructured":"Shafiq M, Da Vela S, Amin L, Younas N, Harris DA, Zerr I, et al. The prion protein and its ligands: insights into structure-function relationships. Biochim Biophys Acta Mol Cell Res. 2022;1869(6):119240. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119240.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1609_CR85","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ncomms1341","volume":"2","author":"DB Freir","year":"2011","unstructured":"Freir DB, Nicoll AJ, Klyubin I, Panico S, McDonald JM, Risse E, et al. Interaction between prion protein and toxic amyloid \u03b2 assemblies can be therapeutically targeted at multiple sites. Nat Commun. 2011;2:336. https:\/\/doi.org\/10.1038\/ncomms1341.","journal-title":"Nat Commun"},{"issue":"5","key":"1609_CR86","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/1074-5521(95)90049-7","volume":"2","author":"SL Kazmirski","year":"1995","unstructured":"Kazmirski SL, Alonso DO, Cohen FE, Prusiner SB, Daggett V. Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implications for scrapie formation. Chem Biol. 1995;2(5):305\u201315. https:\/\/doi.org\/10.1016\/1074-5521(95)90049-7.","journal-title":"Chem Biol"},{"issue":"51","key":"1609_CR87","doi-asserted-by":"publisher","first-page":"44234","DOI":"10.1074\/jbc.M111.286195","volume":"286","author":"L Westergard","year":"2011","unstructured":"Westergard L, Turnbaugh JA, Harris DA. A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J Biol Chem. 2011;286(51):44234\u201342. https:\/\/doi.org\/10.1074\/jbc.M111.286195.","journal-title":"J Biol Chem"},{"issue":"1","key":"1609_CR88","doi-asserted-by":"publisher","first-page":"e0169571","DOI":"10.1371\/journal.pone.0169571","volume":"12","author":"V Mattei","year":"2017","unstructured":"Mattei V, Martellucci S, Santilli F, Manganelli V, Garofalo T, Candelise N, et al. Morphine withdrawal modifies prion protein expression in rat hippocampus. PLoS ONE. 2017;12(1):e0169571. https:\/\/doi.org\/10.1371\/journal.pone.0169571.","journal-title":"PLoS ONE"},{"issue":"48","key":"1609_CR89","doi-asserted-by":"publisher","first-page":"18946","DOI":"10.1073\/pnas.0706522104","volume":"104","author":"NJ Cobb","year":"2007","unstructured":"Cobb NJ, S\u00f6nnichsen FD, McHaourab H, Surewicz WK. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A. 2007;104(48):18946\u201351. https:\/\/doi.org\/10.1073\/pnas.0706522104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6587","key":"1609_CR90","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/382180a0","volume":"382","author":"R Riek","year":"1996","unstructured":"Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, W\u00fcthrich K. NMR structure of the mouse prion protein domain PrP(121\u2013231). Nature. 1996;382(6587):180\u20132. https:\/\/doi.org\/10.1038\/382180a0.","journal-title":"Nature"},{"issue":"21","key":"1609_CR91","doi-asserted-by":"publisher","first-page":"21948","DOI":"10.1074\/jbc.M400793200","volume":"279","author":"R Yadavalli","year":"2004","unstructured":"Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA, Telling GC. Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J Biol Chem. 2004;279(21):21948\u201356. https:\/\/doi.org\/10.1074\/jbc.M400793200.","journal-title":"J Biol Chem"},{"issue":"12","key":"1609_CR92","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.1074\/jbc.M312105200","volume":"279","author":"ET Parkin","year":"2004","unstructured":"Parkin ET, Watt NT, Turner AJ, Hooper NM. Dual mechanisms for shedding of the cellular prion protein. J Biol Chem. 2004;279(12):11170\u20138. https:\/\/doi.org\/10.1074\/jbc.M312105200.","journal-title":"J Biol Chem"},{"issue":"44","key":"1609_CR93","doi-asserted-by":"publisher","first-page":"eadi7347","DOI":"10.1126\/sciadv.adi7347","volume":"9","author":"MJ do Amaral","year":"2023","unstructured":"do Amaral MJ, Mohapatra S, Passos AR, Lopes da Silva TS, Carvalho RS, da Silva Almeida M, et al. Copper drives prion protein phase separation and modulates aggregation. Sci Adv. 2023;9(44):eadi7347. https:\/\/doi.org\/10.1126\/sciadv.adi7347.","journal-title":"Sci Adv"},{"issue":"8","key":"1609_CR94","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/cells8080770","volume":"8","author":"G Salzano","year":"2019","unstructured":"Salzano G, Giachin G, Legname G. Structural consequences of copper binding to the prion protein. Cells. 2019;8(8):770. https:\/\/doi.org\/10.3390\/cells8080770.","journal-title":"Cells"},{"issue":"1","key":"1609_CR95","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.1038\/s41598-020-63472-z","volume":"10","author":"JA Carroll","year":"2020","unstructured":"Carroll JA, Groveman BR, Williams K, Moore R, Race B, Haigh CL. Prion protein N1 cleavage peptides stimulate microglial interaction with surrounding cells. Sci Rep. 2020;10(1):6654. https:\/\/doi.org\/10.1038\/s41598-020-63472-z.","journal-title":"Sci Rep"},{"issue":"16","key":"1609_CR96","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1016\/j.jmb.2020.05.020","volume":"432","author":"KM Schilling","year":"2020","unstructured":"Schilling KM, Tao L, Wu B, Kiblen JTM, Ubilla-Rodriguez NC, Pushie MJ, et al. Both N-terminal and C-terminal histidine residues of the prion protein are essential for copper coordination and neuroprotective self-regulation. J Mol Biol. 2020;432(16):4408\u201325. https:\/\/doi.org\/10.1016\/j.jmb.2020.05.020.","journal-title":"J Mol Biol"},{"issue":"22","key":"1609_CR97","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1021\/bi027138+","volume":"42","author":"CS Burns","year":"2003","unstructured":"Burns CS, Aronoff-Spencer E, Legname G, Prusiner SB, Antholine WE, Gerfen GJ, et al. Copper coordination in the full-length, recombinant prion protein. Biochemistry. 2003;42(22):6794\u2013803. https:\/\/doi.org\/10.1021\/bi027138+.","journal-title":"Biochemistry"},{"issue":"7","key":"1609_CR98","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1074\/jbc.M309570200","volume":"279","author":"J Heske","year":"2004","unstructured":"Heske J, Heller U, Winklhofer KF, Tatzelt J. The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem. 2004;279(7):5435\u201343. https:\/\/doi.org\/10.1074\/jbc.M309570200.","journal-title":"J Biol Chem"},{"key":"1609_CR99","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/bs.pmbts.2020.08.008","volume":"175","author":"C Scial\u00f2","year":"2020","unstructured":"Scial\u00f2 C, Legname G. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates. Prog Mol Biol Transl Sci. 2020;175:297\u2013323. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.008.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"34","key":"1609_CR100","doi-asserted-by":"publisher","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","volume":"285","author":"S Chen","year":"2010","unstructured":"Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues. J Biol Chem. 2010;285(34):26377\u201383. https:\/\/doi.org\/10.1074\/jbc.M110.145516.","journal-title":"J Biol Chem"},{"issue":"5","key":"1609_CR101","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","volume":"79","author":"JW Um","year":"2013","unstructured":"Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein. Neuron. 2013;79(5):887\u2013902. https:\/\/doi.org\/10.1016\/j.neuron.2013.06.036.","journal-title":"Neuron"},{"issue":"3","key":"1609_CR102","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, et al. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol. 2020;139(3):503\u201326. https:\/\/doi.org\/10.1007\/s00401-019-02114-9.","journal-title":"Acta Neuropathol"},{"key":"1609_CR103","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M. Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci. 2015;38:87\u2013103. https:\/\/doi.org\/10.1146\/annurev-neuro-071714-033828.","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"1609_CR104","first-page":"163","volume":"24","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Scialo C, Ristori T. The prion-like propagation of amyloid-beta and tau proteins in Alzheimer\u2019s disease. Trends Mol Med. 2018;24(2):163\u201375.","journal-title":"Trends Mol Med"},{"issue":"2","key":"1609_CR105","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, et al. Two randomized phase 3 Studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9(2):197\u2013210. https:\/\/doi.org\/10.14283\/jpad.2022.30.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"1609_CR106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"issue":"5","key":"1609_CR107","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamaneurol.2025.0065","volume":"82","author":"JA Zimmer","year":"2025","unstructured":"Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, et al. Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials. JAMA Neurol. 2025;82(5):461\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0065.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1609_CR108","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","volume":"288","author":"BR Fluharty","year":"2013","unstructured":"Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, Borsello T, Gobbi M, Harris DA. An N-terminal fragment of the prion protein binds to amyloid-\u03b2 oligomers and inhibits their neurotoxicity in vivo. J Biol Chem. 2013;288(11):7857\u201366. Epub 2013 Jan 28. PMID: 23362282; PMCID: PMC3597823.","journal-title":"J Biol Chem"},{"issue":"2","key":"1609_CR109","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1609_CR110","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/WNL.0000000000200878","volume":"99","author":"G Bellomo","year":"2022","unstructured":"Bellomo G, De Luca CMG, Paoletti FP, Gaetani L, Moda F, Parnetti L. \u03b1-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward. Neurology. 2022;99(5):195\u2013205. https:\/\/doi.org\/10.1212\/WNL.0000000000200878.","journal-title":"Neurology"},{"key":"1609_CR111","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1038\/s41598-017-03373-w","volume":"7","author":"L Urrea","year":"2017","unstructured":"Urrea L, Segura-Anaya E, et al. Prion protein facilitates \u03b1-synuclein amyloid propagation in vivo. Sci Rep. 2017;7:3040.","journal-title":"Sci Rep"},{"key":"1609_CR112","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12868-017-0340-9","volume":"18","author":"S Aulic","year":"2017","unstructured":"Aulic S, Le TT, Moda F, et al. Defined \u03b1-synuclein prion-like molecular assemblies spreading in cell culture. BMC Neurosci. 2017;18:21.","journal-title":"BMC Neurosci"},{"key":"1609_CR113","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21:1332\u201340.","journal-title":"Nat Neurosci"},{"key":"1609_CR114","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nn.3761","volume":"17","author":"E Pecho-Vrieseling","year":"2014","unstructured":"Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P, et al. Transneuronal propagation of mutant huntingtin contributes to non\u2013cell autonomous pathology in neurons. Nat Neurosci. 2014;17:1064\u201372.","journal-title":"Nat Neurosci"},{"issue":"3","key":"1609_CR115","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1074\/jbc.M110.178376","volume":"286","author":"S Giorgetti","year":"2011","unstructured":"Giorgetti S, Raimondi S, Pagano K, Relini A, Bucciantini M, Corazza A, Fogolari F, Codutti L, Salmona M, Mangione P, Colombo L, De Luigi A, Porcari R, Gliozzi A, Stefani M, Esposito G, Bellotti V, Stoppini M. Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J Biol Chem. 2011;286(3):2121\u201331. https:\/\/doi.org\/10.1074\/jbc.M110.178376 Epub 2010 Nov 10. PMID: 21068391; PMCID: PMC3023509.","journal-title":"J Biol Chem"},{"key":"1609_CR116","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker M, Walker LC. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat Neurosci. 2018;21:1341\u20139.","journal-title":"Nat Neurosci"},{"issue":"5","key":"1609_CR117","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","volume":"300","author":"F Tagliavini","year":"2000","unstructured":"Tagliavini F, Forloni G, Colombo L, et al. Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro. J Mol Biol. 2000;300(5):1309\u201322. https:\/\/doi.org\/10.1006\/jmbi.2000.3840.","journal-title":"J Mol Biol"},{"issue":"16","key":"1609_CR118","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1073\/pnas.162284999","volume":"99","author":"G Forloni","year":"2002","unstructured":"Forloni G, Iussich S, Awan T, et al. Tetracyclines affect prion infectivity. Proc Natl Acad Sci United States Am (PNAS). 2002;99(16):10849\u201354. https:\/\/doi.org\/10.1073\/pnas.162284999.","journal-title":"Proc Natl Acad Sci United States Am (PNAS)"},{"issue":"34","key":"1609_CR119","first-page":"22604","volume":"283","author":"A De Luigi","year":"2008","unstructured":"De Luigi A, Colombo L, Diomede L, et al. Doxycycline inhibits prion protein aggregation and toxicity. J Biol Chem. 2008;283(34):22604\u201314.","journal-title":"J Biol Chem"},{"issue":"4","key":"1609_CR120","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s12035-019-01847-8","volume":"57","author":"E Paldino","year":"2020","unstructured":"Paldino E, Balducci C, La Vitola P, Artioli L, D\u2019Angelo V, Giamp\u00e0 C, et al. Neuroprotective effects of doxycycline in the R6\/2 mouse model of Huntington\u2019s disease. Mol Neurobiol. 2020;57(4):1889\u2013903. https:\/\/doi.org\/10.1007\/s12035-019-01847-8.","journal-title":"Mol Neurobiol"},{"key":"1609_CR121","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-2009-1110","volume":"17","author":"F Meyne","year":"2009","unstructured":"Meyne F, Friederike Gloeckner S, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, et al. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis. 2009;17:863\u201373.","journal-title":"J Alzheimers Dis"},{"issue":"s1","key":"1609_CR122","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.4081\/ejh.2021.3298","volume":"65","author":"FA Cazzaniga","year":"2021","unstructured":"Cazzaniga FA, Bistaffa E, De Luca CMG, Bufano G, Indaco A, Giaccone G, et al. Sporadic Creutzfeldt Jakob disease: real-time quaking-induced conversion (RT-QuIC) assay represents a major diagnostic advance. Eur J Histochem. 2021;65(s1):3298. https:\/\/doi.org\/10.4081\/ejh.2021.3298.","journal-title":"Eur J Histochem"},{"issue":"6","key":"1609_CR123","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orr\u00fa","year":"2014","unstructured":"Orr\u00fa CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, et al. A Test for Creutzfeldt\u2013Jakob disease using nasal brushings. N Engl J Med. 2014;371(6):519\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1315200.","journal-title":"N Engl J Med"},{"issue":"1","key":"1609_CR124","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00401-024-02661-2","volume":"147","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi Q, Xiao K, Kong Y, Liang DL, Wang Y, et al. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases. Acta Neuropathol. 2024;147(1):17. https:\/\/doi.org\/10.1007\/s00401-024-02661-2.","journal-title":"Acta Neuropathol"},{"key":"1609_CR125","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/biom10030405","volume":"10","author":"G Giaccone","year":"2020","unstructured":"Giaccone G, Moda F. PMCA applications for prion detection in peripheral tissues of patients with variant Creutzfeldt-Jakob disease. Biomolecules. 2020;10:405.","journal-title":"Biomolecules"},{"issue":"2","key":"1609_CR126","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bcmd.2005.06.013","volume":"35","author":"I Porto-Carreiro","year":"2005","unstructured":"Porto-Carreiro I, F\u00e9vrier B, Paquet S, Vilette D, Raposo G. Prions and exosomes: from PrPC trafficking to PrPSc propagation. Blood Cells Mol Dis. 2005;35(2):143\u20138. https:\/\/doi.org\/10.1016\/j.bcmd.2005.06.013.","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"1609_CR127","doi-asserted-by":"publisher","first-page":"101642","DOI":"10.1016\/j.jbc.2022.101642","volume":"298","author":"SL Gonias","year":"2022","unstructured":"Gonias SL, Banki MA, Azmoon P, Romero HK, Sigurdson CJ, Mantuano E, et al. Cellular prion protein in human plasma-derived extracellular vesicles promotes neurite outgrowth via the NMDA receptor\u2013LRP1 receptor system. J Biol Chem. 2022;298(3):101642. https:\/\/doi.org\/10.1016\/j.jbc.2022.101642.","journal-title":"J Biol Chem"},{"key":"1609_CR128","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3233\/JAD-160740","volume":"55","author":"A Abu Rumeileh","year":"2017","unstructured":"Abu Rumeileh A, Lattanzio F, Stanzani Maserati M, Rizzi R, Capellari S, Parchi P. Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and A\u03b242 in the differential diagnosis of creutzfeldt-jakob disease from Alzheimer\u2019s disease with emphasis on atypical disease variants. J Alzheimers Dis. 2017;55:1471\u201380.","journal-title":"J Alzheimers Dis"},{"key":"1609_CR129","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/v14020276","volume":"14","author":"P Hermann","year":"2022","unstructured":"Hermann P, Haller P, Goebel S, Bunck T, Schmidt C, Wiltfanget J, et al. Total and phosphorylated cerebrospinal fluid Tau in the differential diagnosis of sporadic creutzfeldt-jakob disease and rapidly progressive Alzheimer\u2019s disease. Viruses. 2022;14:276.","journal-title":"Viruses"},{"key":"1609_CR130","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43:32\u201340.","journal-title":"Ann Neurol"},{"key":"1609_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-022-02891-7","volume":"59","author":"M Schmitz","year":"2022","unstructured":"Schmitz M, Canaslan S, Espinosa JC, Fern\u00e1ndez-Borges N, Villar-Piqu\u00e9 A, Llorens F, et al. Validation of plasma and CSF neurofilament light chain as an early marker for sporadic Creutzfeldt-Jakob disease. Mol Neurobiol. 2022;59:1\u20139.","journal-title":"Mol Neurobiol"},{"key":"1609_CR132","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwindet MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20:235\u201346.","journal-title":"Lancet Neurol"},{"key":"1609_CR133","doi-asserted-by":"crossref","unstructured":"Shir D, Lazar EB, Graff-Radford J, Aksamit AJ, Cutsforth-Gregory JK, Joneset DT et al. Analysis of clinical features, diagnostic tests, and biomarkers in patients with suspected Creutzfeldt-Jakob disease, 2014\u20132021. J.","DOI":"10.1002\/alz.062598"},{"issue":"15","key":"1609_CR134","doi-asserted-by":"publisher","first-page":"e170121","DOI":"10.1172\/jci.insight.170121","volume":"8","author":"E Mantuano","year":"2023","unstructured":"Mantuano E, Zampieri C, Azmoon P, Gunner CB, Heye KR, Gonias SL. An LRP1-binding motif in PrPC replicates signaling activities of the full-length protein. JCI Insight. 2023;8(15):e170121. https:\/\/doi.org\/10.1172\/jci.insight.170121.","journal-title":"JCI Insight"},{"issue":"1","key":"1609_CR135","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-018-0248-6","volume":"13","author":"L Linsenmeier","year":"2018","unstructured":"Linsenmeier L, Mohammadi B, Wetzel S, Puig B, Jackson WS, Hartmann A, et al. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein. Mol Neurodegener. 2018;13(1):18. https:\/\/doi.org\/10.1186\/s13024-018-0248-6.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1609_CR136","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tibs.2024.11.004","volume":"50","author":"AR Castle","year":"2025","unstructured":"Castle AR, Dutta A, Lehmann S, Soto C. Prion protein endoproteolysis and its role in health and disease. Trends Biochem Sci. 2025;50(1):45\u201360. https:\/\/doi.org\/10.1016\/j.tibs.2024.11.004.","journal-title":"Trends Biochem Sci"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-026-01609-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01609-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01609-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:01:08Z","timestamp":1788310868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-026-01609-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1609"],"URL":"https:\/\/doi.org\/10.1186\/s13578-026-01609-9","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}